• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度一家三级眼科护理中心的经验:葡萄膜炎患者发生中心性浆液性脉络膜视网膜病变的临床特征。

Clinical profile of uveitis patients developing central serous chorioretinopathy: An experience at a tertiary eye care center in India.

机构信息

Department of Uvea, Sankara Nethralaya, Chennai, Tamil Nadu, India.

Department of Vitreoretina, Sankara Nethralaya, Chennai, Tamil Nadu, India.

出版信息

Indian J Ophthalmol. 2019 Feb;67(2):247-251. doi: 10.4103/ijo.IJO_831_18.

DOI:10.4103/ijo.IJO_831_18
PMID:30672479
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6376845/
Abstract

PURPOSE

To evaluate clinical profile of patients with uveitis who developed central serous chorioretinopathy (CSC).

METHODS

Retrospective case series of consecutive patients of uveitis with CSC managed at a tertiary eye care center in India between 1994 and 2014. The data about clinical features, investigations, treatment, and outcomes were obtained from their medical records.

RESULTS

A total of 31 eyes of 26 patients with uveitis with a diagnosis of CSC between June 1994 and May 2014 were included in the study. The mean age of presentation was 42.8 ± 9.2 years, and 88.4% of the patients were male. CSC was bilateral in 19.2% of the patients, and in 38.4% patients uveitis was because of infectious etiology. CSC developed in 23 (88.5%) patients when they were on oral corticosteroid. The most common cause of uveitis in our study was choroiditis (48.4%), followed by retinal vasculitis (12.9%). The mean time for resolution of CSC was relatively less in patients with uveitis because of infectious etiology. In 10% eyes vision remained the same and deterioration of vision was noted in 19% eyes. Best corrected visual acuity of the patients at the time of presentation with CSC was 0.56 ± 0.34 and after the resolution of CSC was 0.48 ± 0.5 (P < 0.0005).

CONCLUSION

Patients with choroidal inflammations are more prone to develop CSC compared with other subtypes of uveitis. Management of CSC in uveitis can be challenging.

摘要

目的

评估发生中心性浆液性脉络膜视网膜病变(CSC)的葡萄膜炎患者的临床特征。

方法

本研究为回顾性连续病例系列研究,纳入了 1994 年至 2014 年期间在印度一家三级眼科中心接受治疗的葡萄膜炎合并 CSC 患者。从病历中获取了有关临床特征、检查、治疗和结局的数据。

结果

研究共纳入了 31 只眼(26 例患者),这些患者均于 1994 年 6 月至 2014 年 5 月间被诊断为葡萄膜炎合并 CSC。发病时的平均年龄为 42.8±9.2 岁,88.4%的患者为男性。19.2%的患者 CSC 为双侧性,38.4%的患者葡萄膜炎病因是感染性的。23 例(88.5%)患者在口服皮质类固醇时发生 CSC。本研究中最常见的葡萄膜炎病因是脉络膜炎(48.4%),其次是视网膜血管炎(12.9%)。葡萄膜炎病因是感染性的患者的 CSC 缓解时间相对较短。10%的眼视力保持不变,19%的眼视力恶化。发生 CSC 时患者的最佳矫正视力为 0.56±0.34,CSC 缓解后的最佳矫正视力为 0.48±0.5(P<0.0005)。

结论

与其他类型的葡萄膜炎相比,葡萄膜炎症患者更易发生 CSC。葡萄膜炎合并 CSC 的治疗可能具有挑战性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d25c/6376845/035416000eae/IJO-67-247-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d25c/6376845/035416000eae/IJO-67-247-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d25c/6376845/035416000eae/IJO-67-247-g001.jpg

相似文献

1
Clinical profile of uveitis patients developing central serous chorioretinopathy: An experience at a tertiary eye care center in India.印度一家三级眼科护理中心的经验:葡萄膜炎患者发生中心性浆液性脉络膜视网膜病变的临床特征。
Indian J Ophthalmol. 2019 Feb;67(2):247-251. doi: 10.4103/ijo.IJO_831_18.
2
Clinical evaluation of neovascular and non-neovascular chronic central serous chorioretinopathy (CSC) diagnosed by swept source optical coherence tomography angiography (SS OCTA).经扫频源光学相干断层扫描血管造影(SS OCTA)诊断的新生血管性和非新生血管性慢性中心性浆液性脉络膜视网膜病变(CSC)的临床评估
Graefes Arch Clin Exp Ophthalmol. 2019 Aug;257(8):1581-1590. doi: 10.1007/s00417-019-04297-z. Epub 2019 Apr 29.
3
Multimodal Imaging in Fibrinous Central Serous Chorioretinopathy Compared with Exudative Maculopathy.与渗出性黄斑病变相比,纤维蛋白性中心性浆液性脉络膜视网膜病变的多模态成像
Ophthalmologica. 2020;243(5):360-369. doi: 10.1159/000504052. Epub 2020 Jan 31.
4
Patient characteristics and risk factors for central serous chorioretinopathy: an analysis of 811 patients.患者特征和中心性浆液性脉络膜视网膜病变的危险因素:811 例患者分析。
Br J Ophthalmol. 2019 Jun;103(6):725-729. doi: 10.1136/bjophthalmol-2018-312431. Epub 2018 Jul 12.
5
Evaluation of choroidal hyperreflective dots in acute and chronic central serous chorioretinopathy.评价急性和慢性中心性浆液性脉络膜视网膜病变的脉络膜高反射点。
Indian J Ophthalmol. 2019 Nov;67(11):1850-1854. doi: 10.4103/ijo.IJO_2030_18.
6
Clinical Landscape of Central Serous Chorioretinopathy in Germany: Retina.net CSC Registry Report Number 1.德国中心性浆液性脉络膜视网膜病变的临床概况:Retina.net CSC 登记报告第 1 号。
Ophthalmologica. 2024;247(2):95-106. doi: 10.1159/000535930. Epub 2024 Feb 16.
7
THE INCIDENCE OF NEOVASCULARIZATION IN CENTRAL SEROUS CHORIORETINOPATHY BY OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.光学相干断层扫描血管造影术观察中心性浆液性脉络膜视网膜病变的新生血管发生率。
Retina. 2021 Feb 1;41(2):302-308. doi: 10.1097/IAE.0000000000002810.
8
CHOROIDAL THICKNESS OF CENTRAL SEROUS CHORIORETINOPATHY SECONDARY TO CORTICOSTEROID USE.使用皮质类固醇继发的中心性浆液性脉络膜视网膜病变的脉络膜厚度
Retina. 2017 Aug;37(8):1562-1567. doi: 10.1097/IAE.0000000000001380.
9
Biometric characteristics of eyes with central serous chorioretinopathy.伴有中心性浆液性脉络膜视网膜病变的眼睛的生物测量特征。
Invest Ophthalmol Vis Sci. 2014 Mar 13;55(3):1502-8. doi: 10.1167/iovs.13-13183.
10
Choroidal Vascular Flow Area in Central Serous Chorioretinopathy Using Swept-Source Optical Coherence Tomography Angiography.使用扫频源光学相干断层扫描血管造影术测量中心性浆液性脉络膜视网膜病变的脉络膜血管血流面积
Invest Ophthalmol Vis Sci. 2017 Apr 1;58(4):2002-2010. doi: 10.1167/iovs.17-21417.

引用本文的文献

1
Central Serous Chorioretinopathy and Ocular Comorbidities.中心性浆液性脉络膜视网膜病变及眼部合并症
J Clin Med. 2025 Jan 23;14(3):720. doi: 10.3390/jcm14030720.
2
Outcomes of retinal pigment epithelial detachment in Vogt-Koyanagi-Harada disease: a longitudinal analysis.Vogt-Koyanagi-Harada 病性视网膜色素上皮脱离的转归:一项纵向分析。
BMC Ophthalmol. 2022 Nov 19;22(1):446. doi: 10.1186/s12886-022-02675-6.
3
Response to comments on: Clinical profile of uveitis patients developing central serous chorioretinopathy - An experience at a tertiary eye care center in India.

本文引用的文献

1
Central Serous Chorioretinopathy Misdiagnosed as Posterior Uveitis and the Vicious Circle of Corticosteroid Therapy.中心性浆液性脉络膜视网膜病变误诊为后葡萄膜炎及糖皮质激素治疗的恶性循环
J Ophthalmic Vis Res. 2015 Jul-Sep;10(3):303-8. doi: 10.4103/2008-322X.170352.
2
Associations Between Topical Ophthalmic Corticosteroids and Central Serous Chorioretinopathy: A Taiwanese Population-Based Study.局部用眼科皮质类固醇与中心性浆液性脉络膜视网膜病变之间的关联:一项基于台湾人群的研究。
Invest Ophthalmol Vis Sci. 2015 Jun;56(6):4083-9. doi: 10.1167/iovs.14-16360.
3
Central serous chorioretinopathy: update on pathophysiology and treatment.
对关于“葡萄膜炎患者发生中心性浆液性脉络膜视网膜病变的临床特征——印度一家三级眼科护理中心的经验”评论的回复
Indian J Ophthalmol. 2020 Jan;68(1):269-270. doi: 10.4103/ijo.IJO_1267_19.
4
Comment: Clinical profile of uveitis patients developing central serous chorioretinopathy - An experience at a tertiary eye care center in India.评论:葡萄膜炎患者并发中心性浆液性脉络膜视网膜病变的临床特征——印度一家三级眼科护理中心的经验。
Indian J Ophthalmol. 2019 Jul;67(7):1254-1255. doi: 10.4103/ijo.IJO_331_19.
中心性浆液性脉络膜视网膜病变:发病机制和治疗的最新进展。
Surv Ophthalmol. 2013 Mar-Apr;58(2):103-26. doi: 10.1016/j.survophthal.2012.07.004.
4
Central serous chorioretinopathy, corticosteroids, and uveitis.中心性浆液性脉络膜视网膜病变、皮质类固醇和葡萄膜炎。
Ocul Immunol Inflamm. 2012 Apr;20(2):76-85. doi: 10.3109/09273948.2011.650776.
5
Review and update of central serous chorioretinopathy.中心性浆液性脉络膜视网膜病变的复习与更新。
Curr Opin Ophthalmol. 2011 May;22(3):166-73. doi: 10.1097/ICU.0b013e3283459826.
6
Chronic central serous chorioretinopathy associated with serous retinal detachment in a series of Asian patients.一系列亚洲患者中与浆液性视网膜脱离相关的慢性中心性浆液性脉络膜视网膜病变
Ocul Immunol Inflamm. 2009 Jul-Aug;17(4):269-77. doi: 10.1080/09273940802702579.
7
Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop.用于报告临床数据的葡萄膜炎命名标准化。第一次国际研讨会的结果。
Am J Ophthalmol. 2005 Sep;140(3):509-16. doi: 10.1016/j.ajo.2005.03.057.
8
Central serous chorioretinopathy associated with periocular corticosteroid injection treatment for HLA-B27-associated iritis.与用于HLA - B27相关性虹膜炎的眼周皮质类固醇注射治疗相关的中心性浆液性脉络膜视网膜病变。
Arch Ophthalmol. 2004 Jun;122(6):926-8. doi: 10.1001/archopht.122.6.926.
9
Corticosteroids and central serous chorioretinopathy.皮质类固醇与中心性浆液性脉络膜视网膜病变
Ophthalmology. 2002 Oct;109(10):1834-7. doi: 10.1016/s0161-6420(02)01117-x.
10
Involvement of corticosteroids and catecholamines in the pathogenesis of central serous chorioretinopathy: a rationale for new treatment strategies.皮质类固醇和儿茶酚胺在中心性浆液性脉络膜视网膜病变发病机制中的作用:新治疗策略的理论依据
Ophthalmology. 2002 Oct;109(10):1765-6. doi: 10.1016/s0161-6420(02)01303-9.